Advertisement

Ads Placeholder
Loading...

Ikonisys S.A.

ALIKO.PAEURONEXT
Healthcare
Medical - Devices
1.44
0.00(0.00%)
U.S. Market opens in 7h 38m

Ikonisys S.A. Fundamental Analysis

Ikonisys S.A. (ALIKO.PA) shows weak financial fundamentals with a PE ratio of -7.04, profit margin of -1.94%, and ROE of -17.18%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.34

Areas of Concern

ROE-17.18%
Operating Margin-1.77%
Cash Position-0.11%
Current Ratio0.52
We analyze ALIKO.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -177.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-177.1/100

We analyze ALIKO.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALIKO.PA struggles to generate sufficient returns from assets.

ROA > 10%
-10.78%

Valuation Score

Excellent

ALIKO.PA trades at attractive valuation levels.

PE < 25
-7.04
PEG Ratio < 2
-0.34

Growth Score

Weak

ALIKO.PA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ALIKO.PA shows balanced financial health with some risks.

Debt/Equity < 1
0.17
Current Ratio > 1
0.52

Profitability Score

Weak

ALIKO.PA struggles to sustain strong margins.

ROE > 15%
-1718.18%
Net Margin ≥ 15%
-1.94%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALIKO.PA Expensive or Cheap?

P/E Ratio

ALIKO.PA trades at -7.04 times earnings. This suggests potential undervaluation.

-7.04

PEG Ratio

When adjusting for growth, ALIKO.PA's PEG of -0.34 indicates potential undervaluation.

-0.34

Price to Book

The market values Ikonisys S.A. at 1.06 times its book value. This may indicate undervaluation.

1.06

EV/EBITDA

Enterprise value stands at -15.10 times EBITDA. This is generally considered low.

-15.10

How Well Does ALIKO.PA Make Money?

Net Profit Margin

For every $100 in sales, Ikonisys S.A. keeps $-1.94 as profit after all expenses.

-1.94%

Operating Margin

Core operations generate -1.77 in profit for every $100 in revenue, before interest and taxes.

-1.77%

ROE

Management delivers $-17.18 in profit for every $100 of shareholder equity.

-17.18%

ROA

Ikonisys S.A. generates $-10.78 in profit for every $100 in assets, demonstrating efficient asset deployment.

-10.78%

Following the Money - Real Cash Generation

Operating Cash Flow

Ikonisys S.A. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Ikonisys S.A. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

ALIKO.PA converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-7.04

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.34

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.06

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.42

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.17

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.52

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.17

vs 25 benchmark

ROA

Return on assets percentage

-0.11

vs 25 benchmark

ROCE

Return on capital employed

-0.11

vs 25 benchmark

How ALIKO.PA Stacks Against Its Sector Peers

MetricALIKO.PA ValueSector AveragePerformance
P/E Ratio-7.0428.54 Better (Cheaper)
ROE-17.18%738.00% Weak
Net Margin-193.93%-43982.00% (disorted) Weak
Debt/Equity0.170.34 Strong (Low Leverage)
Current Ratio0.522806.01 Weak Liquidity
ROA-10.78%-14624.00% (disorted) Weak

ALIKO.PA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ikonisys S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ